News Headlines Article

Hype and hope of cancer immunotherapy on our latest BioFlash podcast
San Francisco Business Times

Cancer immunotherapy is hot. But the first-generation of drugs that unleash the immune system to fight cancer work for only one in five patients and against only a small number of cancers. In Episode 2 of our biweekly BioFlash podcast — you can download it here, or go to the Apple iTunes store and subscribe — I speak with Dr. Lewis Lanier of the University of California, San Francisco, about this vital sector of cancer research.